News
12h
Zacks Investment Research on MSNHims & Hers vs. Amwell: Which Telehealth Stock Is the Better Buy?Virtual healthcare services, or telehealth, are rapidly becoming a standard of care in the expanding digital healthcare space ...
HIMS posted stellar Q1 FY 2025; growth fueled by ~2.4M subscribers and $84 average monthly revenue per user. Click here to ...
2d
Zacks Investment Research on MSNHims & Hers Stock Falls Despite the Latest Wegovy Availability OfferHims & Hers Health, Inc. HIMS announced that eligible customers can now access six months of prescription-only Wegovy at a ...
Hims Hers Health Inc (NYSE:HIMS), a telehealth firm known for offering consumer-focused digital healthcare, is reducing its headcount by more than 4% as part of a pivot in its business strategy, ...
Hims & Hers Health continues to fire on all cylinders as a business. Click here to read why HIMS stock is a Buy.
Telemedicine company Hims & Hers has hired Farshad Shadloo to lead communications. As VP of communications, Shadloo reports ...
Hims & Hers Health HIMS is well-positioned for growth as it addresses a vast unmet healthcare market, leveraging a total addressable market of $360M across specialties like mental health ...
Hims & Hers Health, Inc. HIMS announced that eligible customers can now access six months of prescription-only Wegovy at a new, affordable price. The company, via this offer, aims to make proven ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results